Search
Close this search box.
Blog » News » Medisca Inc. to pay $21.75 million to resolve inflated price allegations 

Medisca Inc. to pay $21.75 million to resolve inflated price allegations 

Medisca Inc. to pay $21.75 million for inflating prices

The Justice Department is instructing Medisca Inc. to pay $21.75 million to resolve allegations that it established false and inflated Average Wholesale Prices (AWPs) for two ingredients used in compound prescriptions.

The company’s prescription ingredients ordering system reportedly contained false pricing. This resulted in pharmacies unknowingly submitting prescription claims to the Defense Health Agency.

The agency administers the TRICARE Program for the Departments of Defense and Labor’s federal health care programs.

“When federal healthcare programs are defrauded, it hurts all Americans,” said U.S. Attorney Jaime Esparza for the Western District of Texas. “Taxpayers deserve honest pricing and assurances that the government is never overcharged.”

Medisca Inc. to pay the price for inflated price allegations

Those with specialty prescription needs are referred to compounding pharmacies. They create bespoke prescriptions and orders to suit the needs of the patient. Medisca acted as a supplier to these specialist pharmacies that cannot procure ingredients on the generic marketplace.

The allegations brought forth to Medisca said that the company knowingly “inflated the AWPs for resveratrol (NDC No. 38779-2863) and mometasone furoate (NDC No. 38779-2413) in order to increase the reimbursement that its pharmacy customers received from the federal healthcare programs.”

The Justice Department report revealed that Medisca picked up ingredients like resveratrol for $0.37 per gram but reported the AWP for resveratrol at $777 per gram, creating a “spread of over $775 for each gram of resveratrol used by a pharmacy customer in a compound prescription reimbursed by the federal healthcare programs.”

The supplier carried out a similar process for mometasone furoate. It picked up the ingredients from manufacturers for under “$8 per gram. It repackaged and sold that ingredient to compound pharmacies for over $1,000 per gram. Medisca reported an AWP for mometasone furoate at over $7,300 per gram, thereby creating a spread of approximately $6,300 for each gram of the ingredient used by a pharmacy customer in a compound prescription reimbursed by the federal healthcare programs.”

Medisca vastly exacerbated the prices involved in the supply chain of these ingredients and will now pay $21.75 million to resolve these allegations. The Civil Division’s Commercial Litigation Branch, Fraud Section, and the U.S. Attorney’s Offices for the Eastern District of Texas and the Western District of Texas achieved the resolution.

“The systems establishing federal reimbursements for compounded pharmaceuticals should not be viewed by companies as an opportunity to artificially inflate reimbursements from federal payors such as TRICARE,” said U.S. Attorney Damien M. Diggs for the Eastern District of Texas.

Image: BD Morgan Pixlr.

About Due’s Editorial Process

We uphold a strict editorial policy that focuses on factual accuracy, relevance, and impartiality. Our content, created by leading finance and industry experts, is reviewed by a team of seasoned editors to ensure compliance with the highest standards in reporting and publishing.

TAGS
Financial News Writer and Editor
Brian-Damien Morgan, an accomplished journalist and features writer, boasts a rich career that has evolved across various media platforms. With extensive experience in the print sector of several UK newspapers, Brian transitioned seamlessly into the realm of digital broadcasting and specialized financial content creation. Brian now focuses on finance, technology, legal matters, and the wide spectrum of money-related topics.

About Due

Due makes it easier to retire on your terms. We give you a realistic view on exactly where you’re at financially so when you retire you know how much money you’ll get each month. Get started today.

Categories

Top Trending Posts

Due Fact-Checking Standards and Processes

To ensure we’re putting out the highest content standards, we sought out the help of certified financial experts and accredited individuals to verify our advice. We also rely on them for the most up to date information and data to make sure our in-depth research has the facts right, for today… Not yesterday. Our financial expert review board allows our readers to not only trust the information they are reading but to act on it as well. Most of our authors are CFP (Certified Financial Planners) or CRPC (Chartered Retirement Planning Counselor) certified and all have college degrees. Learn more about annuities, retirement advice and take the correct steps towards financial freedom and knowing exactly where you stand today. Learn everything about our top-notch financial expert reviews below… Learn More